XML 33 R23.htm IDEA: XBRL DOCUMENT v3.21.2
Significant Events in the Reporting Period - Additional Information (Detail)
€ in Millions, $ in Millions
3 Months Ended
Jan. 08, 2021
USD ($)
Mar. 31, 2021
EUR (€)
Disclosure of summary of significant accounting policies [line items]    
Expected Non cash Gain recognised towards Shares | €   € 42.3
VISEN Series B Financing [Member]    
Disclosure of summary of significant accounting policies [line items]    
Proceeds from Borrowings classified as Financing Activities $ 150.0  
VISEN Pharmaceuticals [Member]    
Disclosure of summary of significant accounting policies [line items]    
Equity Investment in Associates $ 12.5  
Proportion of Interest retain in issued and Outstanding shares of Associate 44.00%